[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Reuters Legal [@ReutersLegal](/creator/twitter/ReutersLegal) on x 100.1K followers Created: 2025-07-14 13:58:48 UTC AbbVie's Allergan unit will take rival Revance Therapeutics to trial over allegations that Revance's anti-wrinkle injection Daxxify infringes patents related to Allergan's blockbuster Botox. Subscribe to The Daily Docket:  XXX engagements  [Post Link](https://x.com/ReutersLegal/status/1944758481577521285)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Reuters Legal @ReutersLegal on x 100.1K followers
Created: 2025-07-14 13:58:48 UTC
AbbVie's Allergan unit will take rival Revance Therapeutics to trial over allegations that Revance's anti-wrinkle injection Daxxify infringes patents related to Allergan's blockbuster Botox.
Subscribe to The Daily Docket:
XXX engagements
/post/tweet::1944758481577521285